AdvertisementFDA Fees On Industry Haven't Fixed Delays In Generic Drug ApprovalsSeptember 01, 2016Sydney LupkinfacebookEmailWhere are the generic alternatives to EpiPen and other expensive drugs that have lost patent protection? (Bloomberg via Getty Images)
